Developed over the past few years and underpinned by solid research and development, NEUROLANE (patents pending) prototype provides a unique pairing of unobtrusive, high-precision, wearable and implantable brain recording and stimulation approaches. We aim to revolutionise personalized oncology by developing a wireless, battery-free "lab-on-a-patch" for the non-invasive monitoring of cancer therapy. Our prototype uses a disruptive remote sensor architecture to enable high-sensitivity biosensing and seamless data transmission to clinical platforms. We provide a continuous, real-time feedback loop on pharmacodynamics and metabolic response, enabling more precise and adaptive treatment protocols.
The complex pathophysiology of brain diseases has led, in several cases, to the partial or complete failure of pharmacological interventions, leaving patients with near-palliative care. Neurolane addresses an important unmet need by developing less invasive and more functional implants that will maximise the risk-benefit profile of our transient neurotechnology.
NEUROLANE aims to represent a giant conceptual leap for healthcare ad society that will shift the concept of biomedical interventions from treating to healing and will set the stage for the future implementation of other incurable neurological conditions. The applications are in neurological diagnostics, monitoring and therapeutics.